Vemireddy Lalitha Padmanabha, Ying Grace W, Aqeel Ammar, Baig Shaji, Buddharaju Venkata
Internal Medicine, Chicago Medical School Internal Medicine Residency Program, Northwestern McHenry Hospital, Chicago, USA.
Internal Medicine, Northwestern Medicine McHenry Hospital, Rosalind Franklin University of Medicine and Science, McHenry, USA.
Cureus. 2021 Apr 29;13(4):e14755. doi: 10.7759/cureus.14755.
Renal artery stenosis (RAS) is one of the major causes of resistant/malignant hypertension. It can be described as atherosclerotic or non-atherosclerotic. Atherosclerotic RAS comprises almost 90% of all RAS cases and is a prevalent disease of the elderly. Multiple risk factors contribute to atherosclerosis development, which leads to the release of renin and aldosterone, causing resistant/malignant hypertension. Early recognition is prudent but challenging as there are no early clinical signs. We believe that renal resistive index with supportive clinical, laboratory, and imaging modalities can help select revascularization patients.
肾动脉狭窄(RAS)是顽固性/恶性高血压的主要病因之一。它可分为动脉粥样硬化性或非动脉粥样硬化性。动脉粥样硬化性RAS约占所有RAS病例的90%,是一种常见的老年疾病。多种危险因素促成动脉粥样硬化的发展,进而导致肾素和醛固酮的释放,引起顽固性/恶性高血压。由于没有早期临床症状,早期识别虽谨慎但具有挑战性。我们认为,结合支持性的临床、实验室和影像学检查手段的肾阻力指数有助于选择进行血运重建的患者。